Webinar: Miles for Vision: Behind the Scenes of the London Marathon 2025
The latest webinar from Retina UK.
Search
Search results
Podcast: Meet the Retina UK team
The latest podcast from Retina UK.
Webinar: Ask the expert with Professor Marcela Votruba
Join us for our upcoming webinar!
Podcast: Meet the professionals – Genetic Counsellor
The latest podcast from Retina UK.
Meet our Trustee: Rob Halliwell
Rob is a Chief Technology Officer based in Manchester, with over 20 years’ experience leading technology, software development and digital transformation.
SparingVision completes dosing in PRODYGY trial of SPVNO6 for retinitis pigmentosa.
SparingVision have announced this week that they have dosed all participants in their phase 1/2 PRODYGY clinical trial for SPVN06, a gene agnostic therapy aimed at slowing disease progression in Retinitis Pigmentosa (RP).
Clinical Trial Opportunity for Adults with Stargardt Disease
The clinical trial team at The Retina Clinic London have asked us to share an opportunity to participate in a Phase 1 clinical trial for AAVB 039 for Stargardt Disease.
Ocugen announce Phase 3 enrolment completion for OCU400, the largest gene agnostic therapy trial for RP
Biotechnology company Ocugen has announced the enrolment completion of their phase 3 clinical trial for OCU400.
RECORDING: Annual Conference – 28 September 2024
A recording of the Retina UK Annual Conference on 28 September 2024. The Conference was held at the Pendulum Hotel in Manchester and online.